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HYPERACTlVlPl OF PLATELET FUNCTION IN HUMAN DIABETES 
MELLITUS IS DIFFERENT ACCORDING TO THE TYPE OF RETINDPATHY 
DE LA CRUZ J.P’ , MORENO A.‘,GARCIA CAMPOS J.‘, SANCHEZ DE 
LA CUESTA F.’ 
e. Then, are not references in the liiratura about th+ posibilitv that the 
platelet hvperanivitv in diabetic patients is different according to the tvpe of 
retinqmtbv. The aim d the pmumt studv is tq evatuat4 the platelet function in 
insulin-dependent diebetes meliitus (IDDM) with different tvpes of retinopatv. 
&U&A, The study was carried put on 20 healthy vok~ntews IHV), 20 tDDM 
patients withwt retirmpNbv IDWRI, 16 IDDM patients with background 
mtirmpathv fD6RI. 25 IDDM patkne with ischasmic-prdiative retinopathv 
IOIRI, and 19 IDDM patients with exudative mtirmpsthv (DERI. In blood 
samples. we studied platelet agOm&wnetry Msted in plate&t&h plasma -PRP- 
and whole blood) indumd bv ADP and cdlag%n. platelet production of 
thromboune 6, ITx6,) and II-thmmbcgtobulin I6TG), platelet releaw of ATP. 
and ewthracvm uptake of tnimMiM. 
Em&a. Platdet aporwntion in PRP wa* not statisticallv diem between 
OWUM fp<O.Zl. In whole blood. the concentration of ADP tumc#L) that inhibiis 
50% the maximal pht&t aqpmqation, was 1.61 *0.07 in HV, 1.26*0.00 in 
DWR,0.62tO.OBinDBR,0.56iD.04inDtR,ond0.36+0.02inDER.Platelet 
a~rtqattm induced bv edlew! , and the other parameters of platelet 
activation, &wad a qualitative similar bahwkwr that the ADP-induced pIat& 
awranatton. Ths ewthmcvta of th4 HV incmaead cdlwen-indwxd datelnt 
&&ion in FUP bv 23.6 * 1.6%. in DWR bv 27.1 i 2.2%. in. D6R by 
30.8~35%. in DIR bv 35.3+3.B%. and in OER bv 46k3.396. Ervthmcvtn 
uptake of &n~sine &is hipher in.diabetics than. in HV. and th& wen, 
siqniliativr finssr cwrelatioru bawsen this parameter and all the others that 
indkxted pktmbt activation. 
CwM&&n& We conclude that the diibetic Dfatstet hvoeractivitv is related 
with mythtacyte ftmctlon. perhaps by its hiik capacity if keep out adenosine 
fmmthemediumintDDMwith re*lorwthv. Mwmr, in whda Mocd. plank4 
EXPERIMENTAL DIABETIC RETINOPATHY: INFLUENCE OF SEVERAL 
ANTIPLATELET DRUGS 
MORENO A.‘, DE LA CRUZ J.P* , GARCIA CAMPOS J.‘, SANCHEZ DE 
LA CUESTA F.’ 
eurperP. The aim of the present studv is to evatuata if the influence of tie 
pharmacological mcdifiins in thmmboxane/pmstacvchn b&ace bv awerat 
anti&t&t drugs, affect tlm retinal vascular lernns in stmpmzotocinindumd 
diabetic rats. 
MUhq&. Diabetes ws induced bv strepmzqtqcin. and manhined bv 3 
m&hu. The drugs used were: aspirin (6 m~lKo/dav pa) as p*t&t and 
vascular cvclooxvgensse inhibitor, dipvrklamde (12 moKo/dsv p.0.) as 
prostacyclin (PGI,l rtimulatw, its aswciatia~. diiazol(200 m@Q/dav P.o.) and 
mmidamol 110 moKq/dav p.0.) a* wecifii inhibitors of thmmbmane flx&l 
production. 
Ewull& After 3 months of diabetic evolutirm. platelet awr46atic.n war 26.6% 
higher than in non-diiic rats. TX& svnthmis war incre4wd in 62%. and 
vascular PGI, producti~ was 42.7% tower c~npared m that of nondii 
animats. The inhibition of TX& exerted by aspirin, aspirk! + dipvridamak, dltazol 
or mopidamol was sccompained Mth an incm(io in mtinal vasculmdz~; this 
effects was also obtained when rata received dipvddamok, which pmduced 4” 
increase in PGI, rvntherir, and mainly whan the assc&t&n aspirin+ 
dipvridamole was used (differences between this gmup and nondbbaic rata 
were not statisticallvl. 
IZvmWnu. We ructfjsst that the “69 of drupr that produce an increase in 
PGt, and/or an inhibition of TX& prcduction could avoid the retinal vascular 
lesions in experimental induced diabetic rats. When the aasociatkm aspirin + 
dtpyridamde was used. we observed the better retinal pattern in the 
exowimental diabetes. 
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LASER TREATMENT IN DIABETIC RETINOPATHY ALTERS THE 
MACULAR PATTERN ELECTRORETINOGRAM (PERG). 
MORETTI G ’ CIAVARELLA P.’ FALSE.41 B.2 PORCIATTI V.3 
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Purpose. To understand whether laser treatment (either panretinal or focal) 
of diabetic retinopathy (DR) alters the timction of the macular region. 
‘1 Metho& Transient PERGs to 30’ checks have been recorded in DR patients 
with preexisting partial photocoagulation, before and one month a&r one 
additional treatment (established protocol with Argon laser) of either the 
extramacular retina or the extramacular plus macular region. 
Results. On average, treatment of the peripheral retina causes a 20% 
increase of the PERG amphhuie. Peripheral plus focal macular treatment 
causes a marked decrement (40%) of the PERG amplitude. 
ConclusionxThe results are relevant for both a better understanding of 
action mechanisms of laser treatment and a better evabtion of the 
cost&&it ratio atIer photocoagulation in DR. 
activation is dtffemm accmdinq m & tv& of diabatic retinopathv. 
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